Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR

Objective: To investigate the reversal effect of tuberostemonine on MDR in myelogenous leukemia cells K562/ADR. Methods: Human myelogenous leukemia cells K562 and their adriamycin-resistance cells K562/ADR were used. The growth curve of cells treated by tuberostemonine and the Non-toxic concentratio...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cancer
Asıl Yazarlar: Wang, Yu Jia, Zhao, Huan Dong, Zhu, Cai Feng, Li, Jian, Xie, Hong Juan, Chen, Yu Xiang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2017
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436265/
https://ncbi.nlm.nih.gov/pubmed/28529625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17688
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller